{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:29:15Z","timestamp":1790508555199,"version":"4.1.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>Glioblastoma Multiforme is an aggressive brain cancer affecting children and adults frequently resulting in a short life expectancy. Current cancer therapies include surgery and radiation followed by chemotherapy, which due to their ineffectiveness, requires repeated exposure to the same therapies. Since the 1990s, researchers and doctors have explored other therapies, such as diet therapies, to aid in combating gliomas. The ketogenic diet has gained popularity due to Otto Warburg\u2019s theory that tumor cells prefer \u201caerobic glycolysis\u201d and cannot metabolize ketones. The inability of gliomas to use ketones provides an excellent opportunity to weaken the tumor while protecting healthy cells during cancer treatments. This review will examine some of the current research using the ketogenic diet as a form of cancer therapy to determine if this intervention is manageable and effective in patients with glioblastoma. Peer-reviewed articles from 2009 to 2019 were used. The primary objective is to distinguish differences between pre-clinical and clinical research to determine if the ketogenic diet is reproducible from mouse models into humans to determine its effectiveness. The analysis revealed several limitations of the ketogenic diet as an intervention. The effectiveness is more robust in mice than in human studies. Furthermore, tolerability is marginally supported in human studies requiring more reproducible research to validate that the intervention is manageable and effective in patients with glioblastoma.<\/jats:p>","DOI":"10.3389\/fnut.2023.1110291","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T09:02:43Z","timestamp":1678179763000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Ketogenic therapies for glioblastoma: Understanding the limitations in transitioning from mice to patients"],"prefix":"10.3389","volume":"10","author":[{"given":"Angela D.","family":"Clontz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1743-7075-7-33","article-title":"Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: case report","volume":"7","author":"Zuccoli","year":"2010","journal-title":"Nutr Metab (Lond)"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ijrobp.2018.08.033","article-title":"Late effects of radiation prime the brain microenvironment for accelerated tumor growth","volume":"103","author":"Duan","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJMoa1308345","article-title":"Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma","volume":"370","author":"Chinot","year":"2014","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/cncr.23562","article-title":"Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide","volume":"113","author":"Taal","year":"2008","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e433","DOI":"10.3747\/co.26.4889","article-title":"Feasibility of a modified Atkins diet in glioma patients during radiation and its effect on radiation sensitization","volume":"26","author":"Woodhouse","year":"2019","journal-title":"Curr Oncol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J Gen Physiol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e36197","DOI":"10.1371\/journal.pone.0036197","article-title":"The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma","volume":"7","author":"Abdelwahab","year":"2012","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11060-014-1362-0","article-title":"Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme","volume":"117","author":"Champ","year":"2014","journal-title":"J Neuro-Oncol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1038\/ncomms3935","article-title":"Tumour-associated mutant p53 drives the Warburg effect","volume":"4","author":"Zhang","year":"2013","journal-title":"Nat Commun"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fnut.2018.00020","article-title":"Management of Glioblastoma Multiforme in a patient treated with Ketogenic metabolic therapy and modified standard of care: a 24-month follow-up","volume":"5","author":"Elsakka","year":"2018","journal-title":"Front Nutr"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11060-016-2364-x","article-title":"Changes in cerebral metabolism during ketogenic diet in patients with primary brain tumors: (1)H-MRS study","volume":"132","author":"Artzi","year":"2017","journal-title":"J Neuro-Oncol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.tibs.2019.01.005","article-title":"Ketoacidosis \u2013 where do the protons come from?","volume":"44","author":"Green","year":"2019","journal-title":"Trends Biochem Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e99762","DOI":"10.1172\/jci.insight.99762","article-title":"Hepatic ketogenic insufficiency reprograms hepatic glycogen metabolism and the lipidome","volume":"3","author":"d\u2019Avignon","year":"2018","journal-title":"JCI Insight"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/17446651.2018.1523713","article-title":"Implementing a low-carbohydrate, Ketogenic diet to manage type 2 diabetes mellitus","volume":"13","author":"Westman","year":"2018","journal-title":"Expert Rev Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.3390\/ijms19051396","article-title":"CREBH regulates systemic glucose and lipid metabolism","volume":"19","author":"Nakagawa","year":"2018","journal-title":"Int J Mol Sci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1080\/07315724.1995.10718495","article-title":"Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports","volume":"14","author":"Nebeling","year":"1995","journal-title":"J Am Coll Nutr"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e0155050","DOI":"10.1371\/journal.pone.0155050","article-title":"Anti-tumor effects of Ketogenic diets in mice: a meta-analysis","volume":"11","author":"Klement","year":"2016","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/neuonc\/now088","article-title":"A ketogenic diet increases transport and oxidation of ketone bodies in RG2 and 9L gliomas without affecting tumor growth","volume":"18","author":"De Feyter","year":"2016","journal-title":"Neuro-Oncology"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s42003-019-0455-x","article-title":"Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma","volume":"2","author":"Mukherjee","year":"2019","journal-title":"Commun Biol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12885-016-2337-7","article-title":"Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic diet","volume":"16","author":"Lussier","year":"2016","journal-title":"BMC Cancer"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2329048X18779497","DOI":"10.1177\/2329048X18779497","article-title":"Ketogenic diet in refractory childhood epilepsy: starting with a liquid formulation in an outpatient setting","volume":"5","author":"Weijenberg","year":"2018","journal-title":"Child Neurol Open"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/neuonc\/nox029","article-title":"The neurologic assessment in Neuro-oncology (NANO) scale: a tool to assess neurologic function for integration into the response assessment in Neuro-oncology (RANO) criteria","volume":"19","author":"Nayak","year":"2017","journal-title":"Neuro-Oncology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1758835919853958","DOI":"10.1177\/1758835919853958","article-title":"Ketogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: a feasibility and safety study","volume":"11","author":"van der Louw","year":"2019","journal-title":"Ther Adv Med Oncol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.3892\/ijo.2014.2382","article-title":"ERGO: a pilot study of ketogenic diet in recurrent glioblastoma","volume":"44","author":"Rieger","year":"2014","journal-title":"Int J Oncol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41598-018-36347-7","article-title":"Behaviors of Glioblastoma cells in in vitro microenvironments","volume":"9","author":"Diao","year":"2019","journal-title":"Sci Rep"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.1158\/0008-5472.CAN-11-1553","article-title":"Novel cryo-imaging of the glioma tumor microenvironment reveals migration and dispersal pathways in vivid three-dimensional detail","volume":"71","author":"Burden-Gulley","year":"2011","journal-title":"Cancer Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.15252\/emmm.201606857","article-title":"Genetically engineered mouse models in oncology research and cancer medicine","volume":"9","author":"Kersten","year":"2017","journal-title":"EMBO Mol Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11060-010-0115-y","article-title":"A novel pre-clinical in vivo mouse model for malignant brain tumor growth and invasion","volume":"99","author":"Shelton","year":"2010","journal-title":"J Neuro-Oncol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJM200011093431901","article-title":"Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents","volume":"343","author":"Esteller","year":"2000","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/bjc.2015.238","article-title":"Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma","volume":"113","author":"Wong","year":"2015","journal-title":"Br J Cancer"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cmet.2014.02.006","article-title":"Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population","volume":"19","author":"Levine","year":"2014","journal-title":"Cell Metab"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"6128","DOI":"10.1074\/jbc.M110.166991","article-title":"Amino acids activate mammalian target of rapamycin complex 2 (mTORC2) via PI3K\/Akt signaling","volume":"286","author":"Tato","year":"2011","journal-title":"J Biol Chem"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2023.1110291\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T09:02:46Z","timestamp":1678179766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2023.1110291\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,7]]},"references-count":33,"alternative-id":["10.3389\/fnut.2023.1110291"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2023.1110291","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,7]]},"article-number":"1110291"}}